IT1113438B - Nuove ammidi derivate da acidi pirimidin-5-carbossilici,loro preparazione e loro applicazione in terapia - Google Patents

Nuove ammidi derivate da acidi pirimidin-5-carbossilici,loro preparazione e loro applicazione in terapia

Info

Publication number
IT1113438B
IT1113438B IT20206/79A IT2020679A IT1113438B IT 1113438 B IT1113438 B IT 1113438B IT 20206/79 A IT20206/79 A IT 20206/79A IT 2020679 A IT2020679 A IT 2020679A IT 1113438 B IT1113438 B IT 1113438B
Authority
IT
Italy
Prior art keywords
pyrimidin
therapy
preparation
application
carboxylic acids
Prior art date
Application number
IT20206/79A
Other languages
English (en)
Other versions
IT7920206A0 (it
Inventor
Jean Francois Ancher
Bernard Bucher
Thierry Imbert
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7804921A external-priority patent/FR2417506A1/fr
Priority claimed from FR7902286A external-priority patent/FR2457286A2/fr
Application filed by Delalande Sa filed Critical Delalande Sa
Publication of IT7920206A0 publication Critical patent/IT7920206A0/it
Application granted granted Critical
Publication of IT1113438B publication Critical patent/IT1113438B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/38One sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT20206/79A 1978-02-21 1979-02-15 Nuove ammidi derivate da acidi pirimidin-5-carbossilici,loro preparazione e loro applicazione in terapia IT1113438B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7804921A FR2417506A1 (fr) 1978-02-21 1978-02-21 Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques utiles notamment dans le traitement des troubles du psychisme
FR7902286A FR2457286A2 (fr) 1979-01-30 1979-01-30 Nouveaux amides derives d'acides carboxyliques-5 pyrimidiniques, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
IT7920206A0 IT7920206A0 (it) 1979-02-15
IT1113438B true IT1113438B (it) 1986-01-20

Family

ID=26220449

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20206/79A IT1113438B (it) 1978-02-21 1979-02-15 Nuove ammidi derivate da acidi pirimidin-5-carbossilici,loro preparazione e loro applicazione in terapia

Country Status (13)

Country Link
US (1) US4250178A (it)
JP (1) JPS54130585A (it)
AU (1) AU526298B2 (it)
CA (1) CA1096868A (it)
CH (1) CH639078A5 (it)
DE (1) DE2906461A1 (it)
ES (1) ES477852A1 (it)
GB (1) GB2014984B (it)
GR (1) GR66581B (it)
IT (1) IT1113438B (it)
LU (1) LU80937A1 (it)
NL (1) NL7901333A (it)
SE (1) SE446450B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2133004B (en) * 1982-11-04 1986-06-11 Ici Plc Process for the extraction of metal values and novel metal extractants
US4743605A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase
DE4425143A1 (de) * 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
WO1997009315A1 (en) * 1995-09-01 1997-03-13 Signal Pharmaceuticals, Inc. Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
US5811428A (en) * 1995-12-18 1998-09-22 Signal Pharmaceuticals, Inc. Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
EP1034783B1 (en) * 1997-10-27 2004-12-15 Sumitomo Pharmaceuticals Company, Limited Amide derivatives for the treatment of retinal neurodegenerative disorders
US7504396B2 (en) * 2003-06-24 2009-03-17 Amgen Inc. Substituted heterocyclic compounds and methods of use
TW200827346A (en) 2006-11-03 2008-07-01 Astrazeneca Ab Chemical compounds
TW200836719A (en) * 2007-02-12 2008-09-16 Astrazeneca Ab Chemical compounds
WO2009098501A1 (en) * 2008-02-04 2009-08-13 Astrazeneca Ab Novel crystalline forms of 4- [4- (2-adamantylcarbam0yl) -5-tert-butyl-pyrazol-1-yl] benzoic acid
CN102066335A (zh) * 2008-04-22 2011-05-18 阿斯利康(瑞典)有限公司 取代的嘧啶-5-甲酰胺281
AU2015315177A1 (en) * 2014-09-10 2017-03-16 Epizyme, Inc. Substituted pyrrolidine carboxamide compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789979A (en) * 1954-09-22 1957-04-23 Searle & Co Basically substituted nu-alkyl-2-amino-4-hydroxy-5-pyrimidine carboxamides and salts thereof

Also Published As

Publication number Publication date
DE2906461A1 (de) 1979-08-23
GB2014984B (en) 1982-06-09
GR66581B (it) 1981-03-27
CA1096868A (en) 1981-03-03
SE7901493L (sv) 1979-08-22
IT7920206A0 (it) 1979-02-15
US4250178A (en) 1981-02-10
ES477852A1 (es) 1979-08-01
SE446450B (sv) 1986-09-15
GB2014984A (en) 1979-09-05
CH639078A5 (fr) 1983-10-31
LU80937A1 (fr) 1979-10-29
AU4439279A (en) 1979-07-19
AU526298B2 (en) 1983-01-06
NL7901333A (nl) 1979-08-23
JPS54130585A (en) 1979-10-09

Similar Documents

Publication Publication Date Title
IT7923395A0 (it) N-aril-ossazolidinoni, -ossazolidintioni, -pirrolidinoni, -pirrolidine e -tiazolidinoni, loro procedimento di preparazione eloro applicazione in terapia.
FR2432511B1 (fr) Derives triazoliques, leur preparation et leur application en tant que medicaments
IT1122379B (it) Acidi 2-pirrolidincarbossilici 5-sostituiti,antiipertensivi
IT7968939A0 (it) Resine induribili derivate da lattoni e procedimento per la loro preparazione
FI794006A (fi) Farmaceutiskt preparat omfattande en hjaertglykosid i kombination med en polymer
BE849196A (fr) Derives de l'argininamide, leur preparation et leurs utilisation therapeutiques
IT1094434B (it) Cinnamoil piperazione e cinnamoil omopiperazione,procedimento per la loro preparazione e loro applicazione in terapia
IT1164097B (it) "1,4-di idropiridine loro preparazione e loro applicazione come medicamenti"
IT1113438B (it) Nuove ammidi derivate da acidi pirimidin-5-carbossilici,loro preparazione e loro applicazione in terapia
IT7948950A0 (it) Acidi lattamo-n-acetici e loro ammidi procedimento per prepararli e composizioni terapeutiche che licontengono
IT7950267A0 (it) Amminoglucosidi loro preparazione eloro applicazione come medicamenti
NL7900264A (nl) 4-pyridon-3-carbonzuurderivaten alsmede de bereiding ervan.
BE843679A (fr) Derives de 16,16-spirocycloalkylprostaglandines, leur preparation et leurs utilisations therapeutiques
IT1122914B (it) 2-amminoetil-1-fenil-indoline,loro preparazione e loro applicazione come medicamenti
IT1113449B (it) Derivati della n-fenil-alanina,loro prepatazione e loro impiego come prodotti medicinali
NL7906624A (nl) 3,7-digesubstitueerde-3-cefem-4-carbonzuurverbindingen en hun bereiding.
IT1115363B (it) Amminoalcossibenzofurani,loro procedimento di preparazione e loro applicazione in terapia
IT7948786A0 (it) Derivati del 6,7 benzomorfano loro preparazione e loro applicazione in terapeutica
IT7831447A0 (it) Acidi acil-idrocarbilammino-alcanoici, loro preparazione e loro impiego e anche prodotti medicinali che licontengono.
IT1059875B (it) Benzodiossani 1..4 loro procedimento di preparazione e loro applicazione in terapia
FR2330400A1 (fr) Derives d'acides pyrimidine-7-carboxyliques substitues, leur preparation et leurs utilisations therapeutiques
IT7923000A0 (it) Arilalchil-e arilossialchil-fosfonati e loro preparazione.
BE867776R (fr) Derives d'acides thiazolidinecarboxyliques, leur preparation et leur application
IT7948220A0 (it) Derivati dell'isochinolina loro preparazione e loro applicazione quali medicamenti
IT1062826B (it) Acetammidossime loro procedimento di preparazione e loro applicazione in terapia